


Healthcare News Roundup: Regulatory
HSMN NewsFeed - 29 Oct 2015
BioPharmX Corporation Names AnnaMarie Daniels Executive Vice President of Clinical and Regulatory Affairs
BioPharmX Corporation Names AnnaMarie Daniels Executive Vice President of Clinical and Regulatory Affairs
HSMN NewsFeed - 20 Oct 2015
EndoStim receives CE Mark for full body MRI use with EndoStim II LES Stimulation System
EndoStim receives CE Mark for full body MRI use with EndoStim II LES Stimulation System
HSMN NewsFeed - 12 Oct 2015
Varian Medical Systems Receives CE Mark for its Latest ProBeam(R) Proton Therapy System
Varian Medical Systems Receives CE Mark for its Latest ProBeam(R) Proton Therapy System
HSMN NewsFeed - 12 Oct 2015
St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System
St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System
HSMN NewsFeed - 5 Oct 2015
Novocure Announces CE Mark and First Patient Use of Second Generation Optune System
Novocure Announces CE Mark and First Patient Use of Second Generation Optune System
HSMN NewsFeed - 2 Oct 2015
Amicus Therapeutics Provides U.S. Regulatory Update for Migalastat Monotherapy
Amicus Therapeutics Provides U.S. Regulatory Update for Migalastat Monotherapy
HSMN NewsFeed - 28 Sep 2015
Teva Announces Approval of COPAXONE(R) in Japan for the Prevention of Relapse of Multiple Sclerosis
Teva Announces Approval of COPAXONE(R) in Japan for the Prevention of Relapse of Multiple Sclerosis
HSMN NewsFeed - 10 Sep 2015
Boston Scientific Announces CE Mark for the Vercise(TM) Primary Cell Deep Brain Stimulation System
Boston Scientific Announces CE Mark for the Vercise(TM) Primary Cell Deep Brain Stimulation System
